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A novel factor of interest for growth/plasticity in the brain is pregnane xenobiotic
receptor (PXR). PXR is a liver factor known for its role in xenobiotic clearance and
cholesterol metabolism. It is expressed in the brain, suggesting a potential role for
plasticity, particularly involving cholesterol-based steroids and neurosteroids. Mating
induces synthesis of neurosteroids in the midbrain Ventral Tegmental Area (VTA) of female
rodents, as well as other “plastic” regions of the brain, including the hippocampus,
that may be involved in the consolidation of the mating experience. Reducing PXR
in the VTA attenuates mating-induced biosynthesis of the neurosteroid, 5α-pregnan-
3α-ol-20-one (3α,5α-THP). The 18 kDA translocator protein (TSPO) is one rate-limiting
factor for 3α,5α-THP neurosteroidogenesis. The hypothesis tested was that PXR is an
upstream factor of TSPO for neurosteroidogenesis of 3α,5α-THP in the VTA for lordosis,
independent of peripheral glands. First, proestrous rats were administered a TSPO
blocker (PK11195) and/or 3α,5α-THP following infusions of PXR antisense oligonucleotides
(AS-ODNs) or vehicle to the VTA. Inhibiting TSPO with PK11195 reduced 3α,5α-THP
levels in the midbrain and lordosis, an effect that could be reversed with 3α,5α-THP
administration, but not AS-ODN+3α,5α-THP. Second, proestrous, ovariectomized (OVX),
or ovariectomized/adrenalectomized (OVX/ADX) rats were infused with a TSPO enhancer
(FGIN 1-27) subsequent to AS-ODNs or vehicle to the VTA. PXR AS-ODNs blocked actions
of FGIN 1–27 for lordosis and 3α,5α-THP levels among proestrous > OVX > OVX/ADX
rats. Thus, PXR may be upstream of TSPO, involved in neurosteroidogenesis of 3α,5α-THP
in the brain for plasticity. This novel finding of a liver factor involved in behavioral/neural
plasticity substantiates future studies investigating factors known for their prominent
actions in the peripheral organs, such as the liver, for modulating brain function and its
augmentation.
Keywords: midbrain ventral tegmental area, allopregnanolone, progesterone, cognition, reproduction
INTRODUCTION
Steroid hormones are well-recognized for their role for growth
processes in the body. For example, physiological roles of steroids
hormones for growth are apparent during puberty, with the onset
of the patterned secretion of these steroids from the gonads,
and morphological differences (secondary sex characteristics),
and during pregnancy, with substantial changes in many sys-
tems modulated by steroid hormones (e.g., the progestogens—
progesterone and its metabolites), as two examples. In these two
examples there are obvious physical changes, but the effects,
mechanisms, and brain targets of steroids, such as the pro-
gestogens, for cognitive and behavioral processes, in relation to
the body, are starting to become better understood. Data from
large clinical trials conducted of hormone replacement therapies
(HRTs) (which typically include synthetic compounds to mimic
hormones lost during menopause, estradiol and progesterone),
do not entirely support the basic literature on the beneficial
role of these hormones for brain functions, like enhancements
in learning/memory (described below) and reduction in stroke-
and injury-related pathology (Roof et al., 1992, 1993; Chen et al.,
1999; He et al., 2004; Shapiro, 2006; Billeci et al., 2007). Moreover,
these trials were halted early due to increased cardiovascular
and cancer risks and there was a subsequent backlash against
clinical use of HRTs that did not take into account individual
patient characteristics and risk (Rossouw et al., 2002; Shumaker
et al., 2003;Maki andHenderson, 2012). Together, these examples
substantiate the importance of understanding the role and mech-
anisms of steroids in the body and brain.
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In addition to the controversy of whether the potential bene-
fits of hormones outweigh their risks, there has been controversy
of the role of progestogens for benefiting brain function per se.
Historically, the basic experimental design to understand whether
a particular hormone was necessary and sufficient for a physiolog-
ical process was to assess co-variation in the hormone of interest
and a process and remove the gland that produced the hormone
(extirpation) and replace back the hormone (to see if the process
is abrogated and then reinstated, respectively). In rodent models
of cognitive function, studies assessing natural increases in pro-
gestogens over the estrous cycle, or during and after pregnancy,
support the mnemonic effects of these high, physiological levels
of progestogens in spatial and object recognition tasks (Lambert
et al., 2005; Walf et al., 2006; Kinsley and Lambert, 2008; Paris
and Frye, 2008; Macbeth and Luine, 2010). Moreover, ovariec-
tomy (surgical removal of the ovaries) of young, adult female
rats produces performance deficits in the object recognition and
placement tasks, which can be abrogated with replacement back
with progesterone or its neuroactive metabolite, 5α-pregnan-3α-
ol-20-one (3α,5α-THP, a.k.a. allopregnanolone; Walf et al., 2006;
Frye et al., 2007). However, these beneficial effects of progestogens
are not uniformly observed in other studies, using different tasks,
or dosing and formulation of progestogens, or involving investi-
gations in aged rodents (Murphy et al., 2002; Toung et al., 2004;
see review by Acosta et al., 2013). Together, these data suggest that
progestogens’ effects for cognitive function may be influenced by
task, dosing and formulation of progestogen administered, age
and likely many other factors.
Given that there are many factors that can influence responses
to progestogens for neural processes, an approach that we have
taken is to use the well-characterized behavioral model of repro-
ductive behavior of rodents to investigate progestogens’ mech-
anisms. The notion is that we can begin to understand the
mechanisms of progestogens in regions that have been investi-
gated for decades (hypothalamus and midbrain) for this basic,
hormone-dependent behavior (lordosis, or mating posture of
female rodents), substantiating subsequent studies on suchmech-
anisms in corticolimbic structures underlying complex cognitive
processes. Lordosis only occurs in appropriate neuroendocrine
and environmental context, with reductions in the response sup-
ported by effects of ovariectomy, steroid blockers or environmen-
tal stressors (Uphouse et al., 2005, 2013; reviewed in Frye, 2011;
Frye et al., 2013). From studies using this approach, the effects of
progesterone and/or its metabolite, 3α,5α-THP, in the midbrain
ventral tegmental area (VTA), through novel neurotransmitter
targets (e.g., GABA, dopamine, glutamate, and second messen-
ger cascades) have been supported (reviewed in Frye and Walf,
2008). Interestingly, there is high expression of factors involved
in the metabolism and synthesis of 3α,5α-THP in the VTA (from
precursor of all steroids, cholesterol; reviewed in Frye, 2011), sug-
gesting the importance of 3α,5α-THP production and action in
this region.
Another consideration is that experience can alter hormone
levels (and thereby modify the CNS). An example of this is
mating-induced neurosteroid synthesis. Mating induces synthesis
of neurosteroids in the midbrain VTA of female rodents, as well as
other “plastic” regions of the brain, including the hippocampus
and prefrontal cortex, that may be involved in the consolida-
tion of the mating experience in rodents. There can be dynamic
changes in 3α,5α-THP production in midbrain and corticolim-
bic structures followingmating or other social and environmental
challenges (Purdy et al., 1991; Barbaccia et al., 2001; Agís-Balboa
et al., 2007; Pinna et al., 2008; Pinna and Rasmusson, 2012).
In further support, midbrain 3α,5α-THP levels are higher after
female rats are tested in the paced mating task, compared to stan-
dard mating task (which does not involve females temporally
controlling the frequency of contacts withmales), compared to no
mating (reviewed in Frye, 2011). Thus, our model system is to use
lordosis as a bioassay to further understand mechanisms involved
in 3α,5α-THP synthesis and actions for neural/behavioral
plasticity.
Studies focused on mechanistic questions about progestogens’
actions and production in the VTA, using lordosis as the bioas-
say, have been extended to understand novel targets, such as
the pregnane xenobiotic receptor (PXR), for these responses.
PXR has a well-established role as a ubiquitous and promis-
cuous nuclear receptor in the liver and other excretory organs
(kidneys, intestines) for metabolism and xenobiotic clearance
(Geick et al., 2001; Dussault and Forman, 2002; Francis et al.,
2002; Kliewer et al., 2002). Its role in the CNS was not under-
stood until more recently. Some of the first studies examining
PXR’s role were those focused on its function in the blood-brain-
barrier, which was similar to other excretory organs in the body
(Bauer et al., 2004, 2006; Xu et al., 2005; Harmsen et al., 2007;
Ma et al., 2008; Zhang et al., 2008; Ott et al., 2009). However,
PXR is also expressed in the brain itself, suggesting a poten-
tial role for plasticity, particularly involving steroids (which are
cholesterol-based hormones) and neurosteroids (which are pro-
duced from metabolism of cholesterol in the central nervous sys-
tem itself). For example, for synthesis of 3α,5α-THP, cholesterol is
transported into the mitochondria by way of the 18-kDa translo-
cator protein (TSPO) on the outer mitochondrial membrane.
Inside the mitochondria, cholesterol interacts with steroidogenic
acute regulatory protein and cytochrome P450-dependent side
chain cleavage (P450scc) enzymes (Mellon andDeschepper, 1993;
King et al., 2002; Papadopoulos et al., 2006), as well down-
stream steroidogenic enzymes (5α-reductase, 3α-hydroxysteroid
dehydrogenase) to produce pregnenolone, progesterone, dihy-
droprogesterone, and, ultimately, 3α,5α-THP. A question is the
role of PXR in this pathway. Our interest in PXR as a novel tar-
get was supported by a microarray study in which the gene for
this receptor was expressed in the midbrain following paced mat-
ing of female rodents (reviewed in Frye, 2011). We subsequently
characterized the expression of this receptor in the midbrain
across the estrous cycle of rats (in which we found higher expres-
sion associated with higher progestogen levels; Frye et al., 2012,
2013). Moreover, knocking down PXR expression in the VTA
reduces mating-induced biosynthesis of 3α,5α-THP in the VTA.
Given that TSPO is one rate-limiting factor for 3α,5α-THP neu-
rosteroidogenesis, a question is whether metabolism at TSPO
involves, or requires, PXR for production of 3α,5α-THP. The
hypothesis was that PXR is a necessary upstream factor of TSPO
for neurosteroidogenesis of 3α,5α-THP in the VTA for lordo-
sis, independent of peripheral glands. We assessed the role of
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PXR, and TSPO manipulations in different hormonal contexts
(i.e., over the estrous cycle with extirpation of the ovaries and/or
adrenal glands). First, proestrous rats were administered a TSPO
blocker (PK11195) and/or 3α,5α-THP following infusions of PXR
antisense oligonucleotides (AS-ODNs) or vehicle to the VTA in
Experiment 1. We aimed to determine the extent to which the
TSPO inhibitor may have effects similar to PXR knockdown
and whether this may be reversed with 3α,5α-THP replace-
ment. Second, proestrous (Experiment 2), ovariectomized (OVX;
Experiment 3), or ovariectomized/adrenalectomized (OVX/ADX;
Experiment 4) rats were infused with a TSPO enhancer (FGIN 1–
27) subsequent to AS-ODNs or vehicle to the VTA. We aimed to
determine the extent to which the TSPO enhancer may reverse
effects of PXR knockdown and whether this may be related to
hormonal milieu. Results from these experiments supported the
notion that PXR (traditionally considered a liver factor), may be
upstream of TSPO, acting as a homeostatic regulator involved in




Adult, Long–Evans female rats (n = 236), approximately 55
days of age, were bred in the Life Sciences Laboratory Animal
Care Facility at The University at Albany–SUNY (original
stock: Taconic Farms, Germantown, NY, USA) and/or shipped
from Taconic. Rats were group-housed in polycarbonate cages
with woodchip bedding (45 × 24× 21 cm) in a temperature-
(21 ± 1◦C) and humidity- (50 ± 5%) controlled room in the
Laboratory Animal Care Facility. Rats were maintained on a
12:12 h reversed light cycle (lights off at 0800 hours) with con-
tinuous access to Purina Rat Chow and tap water in their home
cages.
GENERAL PROCEDURE
Four experiments were run, using a between- and within-subjects
design. All experimental rats had stereotaxic surgery to implant
cannulae aimed at the VTA, 7 days before drug manipulations
were initiated. Experimental rats were randomly-assigned to one
treatment condition (between-subjects) within a single exper-
iment, and then were tested in a single battery of behavioral
tasks (within-subjects). The general procedure utilized is depicted
in Figure 1. All experimental techniques in rats were approved
by the Institutional Animal Care and Use Committee at the
University at Albany, where the experiments were conducted.
SURGICAL MANIPULATIONS
All rats in Experiments 1–4 were stereotaxically implanted with
bilateral guide cannulae aimed at the VTA (from bregma:
AP = −5.3, ML = ±0.4, DV = −7.0; Paxinos andWatson, 1986)
under xylazine (12mg/kg) and ketamine (80mg/kg) anesthesia
per prior methods (Frye et al., 2013). Immediately following
stereotaxic surgery, rats were OVX (n = 49; Experiment 3) and/or
OVX/ADX (n = 48; Experiment 4). For OVX/ADX, dorsal inci-
sions were made between the ribs and hip, so that the ovaries
and the adrenals could be isolated. The ovaries were ligated
and removed, and the adrenals were isolated and removed. As
ADX rats are sodium deficient, all rats received a bottle of 0.9%
saline and a bottle of tap water in their home cages to maintain
water/salt balance. Following surgery and prior to testing, animals
were monitored for loss of weight, righting response, flank stim-
ulation response, and/or muscle tone. Only rats that passed neu-
rological evaluations and gained weight following surgery until
behavioral testing commenced were continued in the experiment.
All rats that underwent ADX were validated to have complete
ADX surgery via post-hoc assessment of corticosterone in plasma.
Rats were administered ibuprofen (once per oral, and daily in
FIGURE 1 | Depicts different hormonal conditions and TSPO ligand
infusions in rats (top) and timeline of experimental protocol (bottom). In
Experiment 1, all rats were in the proestrous phase of the estrous cycle and
administered via infusions to the VTA, placebo or PXR AS-ODNs (at hour 0,
24, and 44), followed by an inhibitor of TSPO (PK11195) or saline vehicle
and/or 3α,5α-THP (at hour 44.5). In Experiment 2, all rats were in the
proestrous phase of the estrous cycle and administered via infusions to the
VTA, placebo or PXR AS-ODNs (at hour 0, 24, and 44), followed by an
enhancer of TSPO (FGIN) or saline vehicle (at hour 44.5). In Experiment 3, all
rats were ovariectomized (OVX) and administered subcutaneous injections of
E2 at hour 0 and 24 and then administered via infusions to the VTA, placebo
or PXR AS-ODNs (at hour 0, 24, and 44), followed by an enhancer of TSPO
(FGIN) or saline vehicle (at hour 44.5). In Experiment 4, all rats were OVX and
adrenalectomized (OVX/ADX), and administered subcutaneous injections of
E2 at hour 0 and 24 and then administered via infusions to the VTA, placebo
or PXR AS-ODNs (at hour 0, 24, and 44), followed by an enhancer of TSPO
(FGIN) or saline vehicle (at hour 44.5). All rats were tested at hour 45, and
euthanized for tissue collection immediately after behavioral testing was
complete. In all experiments, knockdown of PXR expression in the VTA was
validated and levels of 3α,5α-THP were measured in the midbrain.
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the recovery period in drinking water; 30mg/kg) as post-surgical
analgesia.
ESTROUS CYCLE
Vaginal epithelium of each rat was collected and examined daily
under a light microscope (between 0800–1000). Rats were cycled
through two normal estrous cycles (4–5 days cycle) prior to
testing. Rats were tested on proestrus (epithelium characterized
by nucleated cells, 4–5 days after the previous occurrence) for
Experiments 1 (n = 68) and 2 (n = 71).
INFUSIONS
For Experiments 1–4, rats received either sterile saline
(0.9% w/v) or PXR AS-ODN infusions. AS-ODNs by (5′
CTTGCGGAAGGGGCACCTCA 3′; made in a concentration of
100 ng/μl; Frye et al., 2012, 2013, 2014, in press) were synthesized
and desalted Invitrogen Life Technologies (Carlsbad, CA). This
PXR AS-ODN strategy decreases expression of PXR in the
midbrain, as measured by quantitative polymerase chain reac-
tion (qPCR) (which was utilized here to validate) and western
blotting (Frye, 2011; Frye et al., 2012, 2013). In Experiment 1,
PK11195 (Tocris Biosciences, R&D Systems, Minneapolis, MN)
was utilized as a TSPO antagonist (compounded by adding
crystalline drug to sterile saline at a concentration of 50 ng
per μl; Bitran et al., 2000; Frye et al., 2006, 2009). 3α,5α-THP
(purchased from Dr. Robert Purdy, Scripps Institute, CA) was
prepared to a concentration of 100 ng per μl in β-cyclodextran
(with 5% concentration of β-cyclodextran in sterile water; Frye
and Rhodes, 2006; Frye et al., 2008a, 2014). In Experiments
2–4, a neurosteroidogenesis enhancer, FGIN 1–27, an agonist
of TSPO was utilized (Petralia and Frye, 2005; Frye et al., 2009,
used in Experiments 2–4). Crystalline FGIN was compounded
in a concentration of 50 ng per μl (Tocris) in sterile saline. Rats
received bilateral infusions of each compound or placebo vehicle.
This infusion protocol has been utilized without any indication of
damaging effects as assessed by behavioral changes, or estradiol
levels (given damage can induce aromatase activity, and thereby
local estradiol levels; Azcoitia et al., 2003); this was determined
by comparing rats that were sham surgerized, had stereotaxic
implantation of cannulae to the VTA, but were not administered
infusions, and those that were administered infusions of saline
vehicle in the same volumes as drugs are administered (Frye
et al., 2013).
ESTRADIOL PRIMING
For Experiment 3 and 4, OVX and OVX/ADX rats were primed
with subcutaneous administration of estradiol(10μg in 0.2 cc
vegetable oil) at 0 and 24 h before behavioral testing.
BEHAVIORAL MEASURES
Our primary interest was in the role of PXR and TSPO for
reproductive responding (as measured in the paced mating task);
however, control measures of exploration, anxiety, and social
interaction were also collected. Behavioral data were simulta-
neously collected by using the Any-maze behavioral assessment
computer program (Stoelting Inc., Wood Lawn, IL; for open field,
elevated plus maze, and social interaction) or a digital video
camera (for paced mating) and trained experimenters.
Control measures- exploration, anxiety, non-sexual social
interaction
Immediately before assessment in the pacedmating task, rats were
tested sequentially in the open field for 5min, the elevated plus
maze for 5min, and the social interaction tasks, as per established
methods (see Frye et al., 2013). Across experiments, there were no
differences between comparisons groups in rats that were tested
for exploratory behavior in the open field, anxiety behavior in the
elevated plusmaze, or social interaction with a female conspecific.
Paced mating
Paced mating was conducted per previous methods (Erskine,
1985; Frye et al., 2013) in an apparatus (37.5 × 75 × 30 cm) that
was divided down the center by a Plexiglas partition. An exper-
imental female has access to both sides of the pacing chamber,
while a stimulus male was confined to one side for a 15-min
test period. Standard measures of mating behavior (lordosis quo-
tients, proceptivity quotients, and aggression quotients) are being
reported herein. Lordosis quotients are the percentage of total
number of lordosis responses per total number of sexual con-
tacts by the male. Aggression/rejection (aggression quotients) are
defined as behaviors such as boxing and kicking the male during
contacts.
TISSUE COLLECTION AND PREPARATION
Immediately after testing, rats were euthanized by rapid decap-
itation and whole brain and trunk blood was collected, frozen,
and stored in a freezer. For brain dissections, punches from the
midbrain, around the VTA, were taken from coronal frozen slices
(approximately 60 microns thick), made anterior and posterior
to the VTA, and used for analyses of PXR expression (described
below). At this time of collecting these slices, whether cannu-
lae/infusion tracks were aimed at the VTA was determined (as
per Frye et al., 2013, 2014). There were a total of n = 17 rats that
had placement outside of the VTA; their data was excluded from
analyses of the data from rats with placement to the VTA. Not
all experimental groups were represented in rats that had missed
sites, precluding systematic analyses of the data from these rats to
those with placement to the VTA. However, in comparing the data
available, the pattern that emerged was that rats with placement
outside of the VTA had responses similar to control groups.
VALIDATION OF PXR KNOCKDOWN FOLLOWING PXR AS-ODNs
Standard qPCR methods were utilized on VTA punches to deter-
mine whether PXR AS-ODN infusions reduced PXR expression
(described in Frye et al., 2013, 2014). Data were analyzed by
comparing PXR values to actin control, and PXR expression is
described as fold-change of the rats infused with PXR AS-ODNs
to those infused with control (saline; Livak and Schmittgen, 2001;
Schmittgen and Livak, 2008; Frye et al., 2013, 2014).
STEROID HORMONE MEASUREMENT
Plasma levels of corticosterone, estradiol, and progesterone
were measured to validate adequacy of ADX, estrous cycle stage
and/or OVX and hormone-priming, respectively. Concentrations
of corticosterone, estradiol, progesterone and 3α,5α-THP
were assessed using standard steroid extraction and radioim-
munoassay (primarily for corticosterone and 3α,5α-THP) or
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commercially-available enzyme-linked immunosorbent assays
(estradiol, progesterone) techniques used by our laboratory
(Frye and Bayon, 1999; Frye et al., 2008a, 2013, 2014, in press).
Concentrations were determined for each sample based upon
concurrent standard curves run in duplicate for each of the
assays. Concentrations reflect the approximate concentrations
of the volume of plasma, or protein concentrations determined
in midbrain homogenate samples measured by a NanoDrop
spectrometer.
STATISTICAL ANALYSES
Analyses of variances (ANOVAs) were used to examine effects
of PXR AS-ODN condition (control, PXR AS-ODN), PK11195
condition (control, PK11195) and 3α,5α,-THP condition (β-
cyclodextrin, 3α,5α,-THP for Experiment 1) and for Experiment
2–4, PXR AS-ODN condition (control, PXR AS-ODN) and FGIN
condition (control, FGIN), and/or testing condition (non tested,
tested) on behavioral and endocrine measures. The assumptions
of homogeneity of variance were supported, suggesting that para-
metric ANOVA tests be utilized as the most appropriate statistic
across experiments. When the α level for statistical significance
was reached (p = 0.05) for main effects and interactions, Fisher’s
Least Significant Differences post-hoc tests were used to determine
group differences.
RESULTS
EXPERIMENT 1: EFFECTS OF TSPO BLOCKER, PK11195, IN PROESTROUS
RATS
Validation of PXR AS-ODNs for PXR expression in the midbrain
Rats infused with PXR AS-ODN had 1.5 fold lower PXR expres-
sion in the midbrain VTA compared to rats infused with control
condition [F(1,29) = 11.9, P < 0.001].
3α,5α-THP levels in the midbrain (Figure 2A)
There was significant interaction between PXR AS-ODN con-
dition and 3α,5α-THP condition [F(1, 60) = 10.7, P < 0.002]
for 3α,5α-THP levels in the midbrain VTA, such that con-
trol rats infused with 3α,5α-THP had higher levels of 3α,5α-
THP levels in the midbrain compared to PXR AS-ODN infu-
sions. There were significant main effects of PXR AS-ODN
[F(1, 60) = 29.7, P < 0.0001], 3α,5α-THP [F(1, 60) = 13.1, P =
0.0007], and PK11195 [F(1, 60) = 7.3, P = 0.01] conditions for
3α,5α-THP levels in the midbrain. Infusions of PXR AS-ODNs
reduced, 3α,5α-THP increased, and PK11195 reduced 3α,5α-
THP levels in midbrain compared to control infusions for each
manipulation.
Lordosis quotients (Figure 2B)
There was an interaction between 3α,5α-THP condition and
PK11195 condition [F(1, 60) = 11.4, P = 0.001] for lordosis
quotients, such that PK11195 reduced lordosis quotients, but
not when co-administered with 3α,5α-THP. There was signifi-
cant interaction between PXR AS-ODN condition and 3α,5α-
THP condition [F(1, 60) = 4.7, P = 0.03] for lordosis quo-
tients, such that control rats infused with 3α,5α-THP had
increased lordosis quotients, but not when co-administered PXR
AS-ODNs. There was a significant main effect of PXR AS-ODN
FIGURE 2 | (A) Depicts the mean (+s.e.m.) 3α,5α-THP levels in the
midbrain of proestrous rats infused first with control and vehicle (veh, n =
5), 3α,5α-THP (n = 7), PK11195 (n = 12), PK11195+3α,5α-THP (n = 11), or
pregnane xenobiotic receptor (PXR) antisense deoxynucleotides (AS-ODNs)
and veh (n = 10), PXR AS-ODN +3α,5α-THP (n = 8), PXR AS-ODN+
PK11195 (n = 7), PXR AS-ODN + PK11195+ 3α,5α-THP (n = 8) in
Experiment 1. (B) Depicts the mean (+s.e.m.) lordosis quotient of
proestrous rats in these conditions. Rats infused with PXR AS-ODN had a
mean 1.5 fold lower PXR expression in the midbrain compared to control
infusions in Experiment 1 (data not shown). ∗above a line indicates a
significant effect of PXR AS-ODNs compared to control infusion (P < 0.05).
∗above a bar indicates a significant effect of PK11195 and
PK1195+3α,5α-THP compared to vehicle infusions (P < 0.05).
condition [F(1, 60) = 12.5, P = 0.0008] to reduce lordosis quo-
tients compared to those infused with control.
Aggression quotients (Table 1)
There was significant main effect of PXR AS-ODN condition
[F(1, 60) = 19.9, P = 0.0003] and PK11195 condition [F(1, 60) =
3.9, P = 0.05] for aggression quotients. Rats infused with PXR
AS-ODN or PK11195 had increased aggression quotients com-
pared to respective control infusions.
EXPERIMENT 2: EFFECTS OF TSPO ENHANCER, FGIN 1–27, IN
PROESTROUS RATS
Validation of PXR AS-ODNs for PXR expression in the midbrain
Rats infused with PXR AS-ODN had 1.8 fold lower PXR expres-
sion in the midbrain VTA compared to rats administered control
infusions [F(1, 37) = 36.4, P < 0.0001].
3α,5α-THP levels in the midbrain (Figure 3A)
There was a significant main effect of PXR AS-ODN condi-
tion [F(1, 52) = 14.4, P = 0.0004] for 3α,5α-THP levels in the
midbrain.Rats infused with PXRAS-ODNhad significantly lower
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Table 1 | Depicts mean (± s.e.m.) aggression quotients (AQ) of rats during the paced mating task In Experiments 1–4.
EXPERIMENT 1
Hormone condition Proestrous
AS-ODN condition Control PXR AS-ODN
Infusion condition Veh 3α,5α-THP PK11195 PK11195 + 3α,5α-THP Veh 3α,5α-THP PK11195 PK11195 + 3α,5α-THP
AQ 33.9 ± 10.6 14.4ˆ ± 8.8 49.2 ± 9.1 12.5 ± 5.1 51.8* ± 18.2 37.9*ˆ ± 7.5 58.3* ± 8.3 46.4* ± 9.7
EXPERIMENT 2
Hormone condition Proestrous
AS-ODN condition Control PXR AS-ODN
FGIN condition Veh FGIN Veh FGIN
AQ 26.5 ± 9.0 30.9 ± 7.6 34.2 ± 12.6 46.5 ± 9.2
EXPERIMENT 3
Hormone condition OVX, E2-primed
AS-ODN condition Control PXR AS-ODN
FGIN condition Veh FGIN Veh FGIN
AQ 40.6 ± 11.6 74.2 ± 10.4 75.2 ± 12.1 66.2 ± 7.9
EXPERIMENT 4
Hormone condition OVX/ADX, E2-primed
AS-ODN condition Control PXR AS-ODN
FGIN condition Veh FGIN Veh FGIN
AQ 39.6 ± 12.9 23.0 ± 10.1 61.1* ± 10.3 66.6* ± 16.0
∗Indicates a significant difference of pregnane xenobiotic receptor (PXR) PXR antisense oliodeoxynucleotides (AS-ODN) from control (P > 0.05).
ˆ Indicates significant interaction between AS-ODN, PK11195, and 3 α, 5 α-THP (P > 0.05).
3α,5α-THP in the midbrain compared to those infused with con-
trol; effects of testing and FGIN infusions did not reach statistical
significance.
Lordosis Quotients (Figure 4A)
There was a significant interaction between PXR AS-ODN condi-
tion and FGIN condition [F(1, 47) = 3.8, P < 0.05] for lordosis
quotients, such that PXR AS-ODNs reduced lordosis, but not
when co-administered with FGIN. There was a significant main
effect of PXR AS-ODN condition [F(1, 47) = 3.8, P = 0.05] for
lordosis quotients. Rats infused with PXR AS-ODN had signifi-
cantly lower lordosis quotients compared to those infused with
control condition.
Aggression quotients (Table 1)
There were no statistically significant effects of conditions for
aggression quotients in this experiment.
EXPERIMENT 3: EFFECTS OF TSPO ENHANCER, FGIN 1–27, IN OVX RATS
Validation of PXR AS-ODNs for PXR expression in the midbrain
Rats infused with PXR AS-ODN had 1.5 fold lower PXR
expression in the midbrain VTA compared to control infusions
[F(1, 41) = 14.2, P = 0.0005].
3α,5α-THP levels in the midbrain (Figure 3B)
There was a main effect for testing condition [F(1, 41) = 16.9,
P = 0.002] for 3α,5α-THP levels in the midbrain, such that tested
rats had higher levels of 3α,5α-THP inmidbrain compared to
non-tested rats; effects of PXR AS-ODN and FGIN infusions did
not reach statistical significance.
Lordosis quotients (Figure 4B)
There was a significant main effect of PXR AS-ODN condition
[F(1, 24) = 18.9, P = 0.0002] and FGIN condition [F(1, 24) = 9.3,
P = 0.005] for lordosis quotients. Rats infused with PXR AS-
ODN had significantly lower, and those infused with FGIN had
significantly higher, lordosis quotients, compared to those infused
with respective control conditions.
Aggression quotients (Table 1)
There were no significant main effects for AS-ODN condition or
FGIN condition for aggression quotients.
EXPERIMENT 4: EFFECTS OF TSPO ENHANCER, FGIN 1–27, IN OVX/ADX
RATS
Validation of PXR AS-ODNs for PXR expression in the midbrain
Rats infused with PXR AS-ODN had 1.4 fold lower PXR
expression in the midbrain VTA compared to control infusions
[F(1, 24) = 6.4, P = 0.01].
3α,5α-THP levels in the midbrain (Figure 3C)
There was main effect of testing condition [F(1, 38) = 10.3, P =
0.002] and PXR AS-ODN condition [F(1, 38) = 4.4, P = 0.04] for
3α,5α-THP levels in the midbrain. Tested rats had higher levels
of 3α,5α-THP in midbrain compared tonon-tested rats, and rats
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FIGURE 3 | (A) Depicts the mean (±s.e.m.) 3α,5α-THP levels in the midbrain
of proestrous non tested rats infused with control and vehicle (veh, n = 5) or
control+FGIN (n = 4), or pregnane xenobiotic receptor (PXR) antisense
deoxynucleotides (AS-ODNs) and veh (n = 6), or PXR AS-ODN+FGIN (n = 6)
or behaviorally-tested rats infused with control+veh (n = 15), control+FGIN
(n = 15), PXR AS-ODN+veh (n = 8), or PXR AS-ODN+FGIN (n = 13) in
Experiment 2. Rats infused with PXR AS-ODN had a mean 1.8 fold lower
PXR expression in the midbrain compared to control infusions in Experiment
2 (data not shown). (B) Depicts the mean (±s.e.m.) 3α,5α-THP levels in the
midbrain of ovariectomized (OVX) estradiol (E2)-primed non tested rats
infused with control+veh (n = 5), control+FGIN (n = 6), PXR AS-ODN+veh
(n = 5), PXR AS-ODN+FGIN (n = 5), or behaviorally-tested rats infused with
control+veh (n = 8), control+FGIN (n = 7), PXR AS-ODN+veh (n = 7), or
PXR AS-ODN+FGIN (n = 6) in Experiment 3. Rats infused with PXR AS-ODN
had a mean 1.5 fold lower PXR expression in the midbrain compared to
control infusions in Experiment 3 (data not shown). (C) Depicts the mean
(±s.e.m.) 3α,5α-THP levels in the midbrain of OVX/adrenalectomized (ADX),
E2-primed rats that were non tested and infused with control+veh (n = 6),
control+FGIN (n = 5), PXR AS-ODN+veh (n = 5), PXR AS-ODN+FGIN
(n = 5), or behaviorally-tested and infused with control+veh (n = 9),
control+FGIN (n = 5), PXR AS-ODN+veh (n = 8), or PXR AS-ODN+FGIN
(n = 5) in Experiment 4. Rats infused with PXR AS-ODN had a mean 1.4 fold
lower PXR expression in the midbrain compared to control infusions in
Experiment 4 (data not shown). ∗above a line indicates a significant effect of
PXR AS-ODNs compared to control. ∗∗above a line indicates significant
effect of testing compared to non-tested rats (P < 0.05).
FIGURE 4 | (A) Depicts the mean (±s.e.m.) lordosis quotients of
proestrous rats infused with control and vehicle (veh, n = 15),
control+FGIN (n = 15), pregnane xenobiotic receptor (PXR) antisense
deoxynucleotides (AS-ODNs)+vehicle (n = 8), or PXR AS-ODN+FGIN
(n = 13) in Experiment 2. (B) Depicts the mean (±s.e.m.) lordosis quotients
of ovariectomized (OVX) estradiol (E2)-primed rats infused with control+veh
(n = 8), control+FGIN (n = 7), PXR AS-ODN+veh (n = 7), or PXR
AS-ODN+FGIN (n = 6) in Experiment 3. (C) Depicts the mean (±s.e.m.)
lordosis quotients of OVX/adrenalectomized (ADX), E2-primed rats infused
with control+veh (n = 9), control+FGIN (n = 5), PXR AS-ODN+veh (n = 8),
or PXR AS-ODN+FGIN (n = 5) in Experiment 4. ∗above a line indicates a
significant effect of PXR AS-ODNs compared to control. (P < 0.05).
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infused with PXR AS-ODNs had lower levels compared to control
infusions.
Lordosis quotients (Figure 4C)
There was main effect of PXR AS-ODN condition [F(1, 25) = 5.8,
P = 0.02] for lordosis quotients, such that infusions of PXR AS-
ODN decreased lordosis quotients compared to control infusions;
effects of FGIN infusions did not reach statistical significance.
Aggression quotients (Table 1)
There was main effect of PXR AS-ODN condition [F(1, 25) =
4.9, P = 0.03] for aggression quotients, such that infusions of
PXR AS-ODN decreased aggression quotients compared to con-
trol infusions; effects of FGIN infusions did not reach statistical
significance.
DISCUSSION
The data support, in part, the hypothesis tested that PXR is
an upstream factor of TSPO for neurosteroidogenesis of 3α,5α-
THP in the VTA for lordosis, independent of peripheral glands.
First, proestrous rats administered a TSPO blocker (PK11195),
subsequent to AS-ODNs to the VTA, had lower 3α,5α-THP
levels in the midbrain and lordosis; the effects on lordosis
could be reversed with replacement with 3α,5α-THP administra-
tion alone, but not when co-administered with PXR AS-ODN.
Second, proestrous, OVX, or OVX/ADX rats infused with a TSPO
enhancer (FGIN 1–27), subsequent to AS-ODNs to the VTA, had
lower 3α,5α-THP levels in the midbrain and lordosis particu-
larly among proestrous rats, compared to those that were OVX
or OVX/ADX. Comparisons with removal of the main periph-
eral sources of steroids, ovaries and adrenals, were completed to
address the role of PXR and TSPO for steroid synthesis in the
brain. These data with a greater response in proestrous com-
pared to rats with glands surgically removed suggest that there
is not complete independence of these peripheral sources for
PXR’s actions in the midbrain VTA, which are likely upstream
of TSPO. Thus, PXR may be acting as a homeostatic regulator,
upstream of TSPO in the pathway for production of 3α,5α-
THP in the midbrain VTA, and behavioral responses of female
rats.
The present data confirm the importance of PXR in the mid-
brain for 3α,5α-THP and lordosis. Inhibiting PXR with the same
AS-ODN approach used here reduces 3α,5α-THP in themidbrain
VTA concomitant with reductions in lordosis and enhancements
in aggressive responding toward males during paced mating of
proestrous rats, or those that were OVX and estradiol-primed
(Frye et al., 2013, 2014). Additionally, activating PXR with ligands
infused to the midbrain VTA enhances reproductive responding
of female rats (Frye, 2011). Moreover, the present data confirm
the role of biosynthesis of 3α,5α-THP from cholesterol in the
midbrain VTA for lordosis. Inhibitors of TSPO, as well as down-
stream factors involved in biosynthesis, StAR or P450scc, infused
to the midbrain VTA of female rats attenuates progestogen-
facilitated lordosis (Petralia et al., 2005; Frye et al., 2008a; Frye,
2009; Frye and Paris, 2011). An opposite effect is observed with
TSPO agonist, such as FGIN, when infused to the midbrain
VTA as was observed here (Frye et al., 2009; Frye and Paris,
2011).
It should be noted that FGIN infusions in this study did not
produce the same pattern of reduction for 3α,5α-THP levels in
the midbrain as was observed in lordosis quotients. A consider-
ation is that this experiment was conducted in proestrous rats,
with peripheral sources of steroids, as well as typical steroid feed-
back mechanisms in place; a more robust response may have been
observed with this FGIN dosing in OVX and/or OVX/ADX rats.
Another consideration is that comparisons with non-tested rats
in this experiment may have provided an indication of mating-
induced 3α,5α-THP production from metabolism of proges-
terone from the ovaries, which could account for little difference
in 3α,5α-THP levels in the midbrain after mating, albeit low lor-
dosis responding with this manipulation. A third consideration
is that measurement of dihydroprogesterone, or other steroids,
were not assessed in the midbrain. Indeed, in the group that
was co-administered PK11195 and 3α,5α-THP, the enhancements
in lordosis were more robust than post-mating levels of 3α,5α-
THP on the midbrain that were measured; whether this could
have been due to back-conversion of administered 3α,5α-THP or
3α,5α-THP from other sources is not known. Together, these data
extends previous findings to suggest that PXR, which is known
to act as a transcription factor for P450 enzymes involved in
steroid metabolism, such as CYP11A1 (Ma et al., 2008; Zhang
et al., 2008), may be another important neuroregulatory factor
in the biosynthesis of 3α,5α-THP in the midbrain, upstream of
TSPO, and resulting actions on lordosis in the adult. Moreover,
the data that there were differences between proestrous, OVX,
and OVX/ADX rats suggest that biosynthesis in the brain, as
well as metabolism from peripheral sources of progesterone, are
involved in PXR’s modulation of 3α,5α-THP. Alternatively, the
removal of the glands disrupts multiple negative feedback loops
of steroids, and thereby disrupts typical responses to steroids for
behavior. We have observed that effects of PXR AS-ODN infu-
sions to reduce lordosis and 3α,5α-THP levels in the midbrain
of OVX rats only when they were estradiol-primed (Frye et al.,
2014). Thus, hormonal milieu provides a significant context for
interactions between neuroendocrine and behavioral responses.
The pattern of results here confirms prior studies showing a
greater influence of PXR knockdown in themidbrain for behavior
in the paced mating task, compared to the other behavioral tasks
assessed (even when the order of testing in these tasks is altered as
in Frye et al., in press). There were very few animals that received
infusions outside the targeted area, and all experimental groups
were not represented. The data from these subjects suggest that
manipulations to other midbrain sites (e.g., substantia nigra, or
central gray) did not produce the same pattern of effects as did
infusions to the VTA, but rather produced responses similar to
the control groups. Manipulations of 3α,5α-THP from exposure
to mating, or infusions of 3α,5α-THP directly to this the mid-
brain (but not substantia nigra or central gray), increase levels
of 3α,5α-THP in corticolimbic structures and reduce anxiety-like
responding; however, manipulations of PXR typically produce
less robust effects on these other measures, as was observed
here. A question for future studies is the expression patterns and
actions of PXR beyond the midbrain for reproduction-relevant
behaviors, such as cognition, exploration, anxiety, and inter-
actions with conspecifics. Mating-induced neurosteroidogenesis
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occurs beyond the midbrain to the hippocampus, cortex, and
striatum (Frye and Rhodes, 2006; Frye et al., 2009). Indeed, we
have observed that manipulating PXR in the midbrain of proe-
strous rats reduces 3α,5α-THP levels in the midbrain and the
hippocampus, as well as a growth factor (brain-derived neu-
rotrophic factor; BDNF) in the hippocampus (Frye et al., 2013,
in press). It is plausible that PXR is having effects beyond those
involving progestogen-facilitated lordosis through actions in the
midbrain.
Beyond facilitating successful mating, progestogens are con-
sidered to have organizing effects on the nervous system dur-
ing gestation/perinatally to influence later adult behaviors that
ultimately are adaptive (reducing stress/anxiety, enhancing cog-
nition, and conferring protection to neural insults/aging; Frye,
2009; Brinton, 2013; Brunton et al., 2014; Bali and Jaggi, 2014).
We have focused on using lordosis as a bioassay to understand
progestogens’ mechanisms and effects in the central nervous sys-
tem; albeit, other models support a role of progestogens for moti-
vated, and cognitive processes. One example is mating-induced
conditioned placed preference, where females will change their
initial preference to spend time in a context associated with mat-
ing (González-Flores et al., 2004; Camacho et al., 2009; Arzate
et al., 2011). Beneficial effects of progesterone or 3α,5α-THP
administration to ovariectomized rats or mice has been described
for spatial and object recognition memory tasks (Sandstrom and
Williams, 2001; Tanabe et al., 2004; Walf et al., 2006; Frye et al.,
2007, 2013). Furthermore, the capacity for de novo steroid syn-
thesis in the prefrontal cortex and hippocampus (Cheng and
Karavolas, 1975; Li et al., 1997; Furukawa et al., 1998; Frye,
2001a,b) suggests that PXR may also be a factor to investigate
systematically in these regions for behaviors that contribute to
successful mating. For example, in recent studies assessing the
requirement of PXR for mating-induced 3α,5α-THP synthesis in
the midbrain and the hippocampus, knocking down PXR attenu-
ated effects of paced mating experience to increase 3α,5α-THP
in these regions, as well as increase BDNF in the hippocam-
pus, of proestrous rats (Frye et al., in press). Given the role of
progestogens throughout the lifespan, the importance of PXR-
mediated 3α,5α-THP production and other measures of neural
plasticity (e.g., BDNF) and behavioral plasticity (e.g., mating) are
of continued interest.
In addition to further understanding potential downstream
factors, such as TSPO and BDNF, the contributory role of other
“liver” factors in the same nuclear receptor super family as PXR,
such as liver X receptor (LXR), for neural and behavioral plas-
ticity needs to be explored. Although the present experiment
focused on the role of PXR, it would be of interest to consider
the respective roles of these factors, which were first described in
the liver, but both have received a greater focus on their effects
in the nervous system more recently (Mellon et al., 2008). One
focus of the effects of these receptors is their role in cholesterol
clearance, which is related to diet and cardiovascular function,
as well as important for neurodegenerative disorders, such as
Alzheimer’s disease, and neurodevelopmental disorders, such as
Niemann-Pick disease (Whitney et al., 2002; Repa et al., 2007; Ma
et al., 2008; Tang et al., 2008). As one example, mouse models
of Niemann-Pick disease show deficits in cholesterol metabolism
and 3α,5α-THP production in the brain, and such deficits could
be reversed with administration of PXR ligands, one of them
being 3α,5α-THP (Frye and Rhodes, 2006; Frye, 2009; Brinton,
2013).
Early developmental effects of LXR in the brain have also
been described. For example, protective effects similar to those
described for PXR have been noted with LXR modulation in a
Niemann-Pick disease mouse model (Repa et al., 2007) as well as
promoting neurosteroidogenesis and protective effects in animal
models of diabetic neuropathy and multiple sclerosis (Cermenati
et al., 2010, 2012; Mitro et al., 2012). As well, the role of LXR
in typical neurodevelopmental processes, such as neurogenesis,
in the VTA of mice, using an in vitro model, has been recently
described (Theofilopoulos et al., 2013). Additionally, knockout
of the beta form of LXR that is highly expressed in the central
nervous system increases anxiety-like responding of female mice
and alters GABA in the cortex (Tan et al., 2012). In the present
study, the role of PXR in the VTA for 3α,5α-THP production from
cholesterol and subsequent behavioral effects was assessed. A con-
sideration for future studies is elucidating how PXR and LXR
may act synergistically for efficient cholesterol metabolism and
clearance in neurons and glia, respectively, supporting neural and
behavioral plasticity. Another important question is the role of
PXR for neurosteroidogenesis in males; production of androstane
neurosteroids, such as 3α-androstanediol, occurs after mating of
male rodents and has robust behavioral actions (Edinger and
Frye, 2007; Frye et al., 2008b). Although proestrous female rats
have higher expression of PXR in the midbrain than do males
(Frye et al., 2013), the expression of PXR in males and females
in other brain regions with high capacity for neurosteroidogene-
sis is not completely known. Together, these results involving liver
factors, such as PXR, substantiate further studies of an interaction
between peripheral and brain factors for behavior.
In summary, inhibiting TSPO with PK11195 reduced 3α,5α-
THP levels in the midbrain and lordosis, an effect that could
be reversed with 3α,5α-THP administration, but not AS-
ODN+3α,5α-THP. PXR AS-ODNs blocked actions of FGIN 1–27
for lordosis and 3α,5α-THP levels among proestrous > OVX >
OVX/ADX rats. Together, these data suggest the liver factor, PXR,
may be upstream of TSPO, acting as a homeostatic regulator
involved in neurosteroidogenesis of 3α,5α-THP in the brain for
behavior. Understanding these basic mechanisms of how steroids
are involved, and what factors are necessary for their production,
for behavioral/neural plasticity supports future work on how a
prominent peripheral factor, such as PXR, may have actions in the
brain and, ultimately, find use in brain augmentation approaches.
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